Official UK visa sponsor profile for Adaptimmune Limited in Abingdon, including current register status, route details, and public company data.
Adaptimmune Limited, registered in England and Wales under registration number 06456741, was established in 2007 and currently maintains an active status. The company operates as a limited company (Ltd) located at 60 Jubilee Avenue, Milton Park, Abingdon, OX14 4RX. Adaptimmune is a clinical-stage biopharmaceutical company specializing in the development of novel cancer immunotherapy products. Its primary focus is on the development of these products for cancer patients. The company’s website indicates a clinical-stage company size, suggesting it is currently in the process of advancing its products through clinical trials. It does not appear to have an international presence. Financial records for the year ending 2024-12-31 show no charges and the company is not insolvent. The company utilizes a Skilled Worker visa, with a worker rating of A. The company’s industry classification under the SIC 72190 code is listed as ‘None’. Adaptimmune’s operations are centered around product development and the advancement of its immunotherapy pipeline. No hiring indicators were observed on the company website.
This summary is AI-generated from public sources (Companies House, the company website, and the official sponsor register) and may not be fully accurate or current. Verify important details against the official Home Office register or the company's own website.
Official UK visa sponsor profile for Adaptimmune Limited in Abingdon, including current register status, route details, and public company data.
Adaptimmune Limited, registered in England and Wales under registration number 06456741, was established in 2007 and currently maintains an active status. The company operates as a limited company (Ltd) located at 60 Jubilee Avenue, Milton Park, Abingdon, OX14 4RX. Adaptimmune is a clinical-stage biopharmaceutical company specializing in the development of novel cancer immunotherapy products. Its primary focus is on the development of these products for cancer patients. The company’s website indicates a clinical-stage company size, suggesting it is currently in the process of advancing its products through clinical trials. It does not appear to have an international presence. Financial records for the year ending 2024-12-31 show no charges and the company is not insolvent. The company utilizes a Skilled Worker visa, with a worker rating of A. The company’s industry classification under the SIC 72190 code is listed as ‘None’. Adaptimmune’s operations are centered around product development and the advancement of its immunotherapy pipeline. No hiring indicators were observed on the company website.
This summary is AI-generated from public sources (Companies House, the company website, and the official sponsor register) and may not be fully accurate or current. Verify important details against the official Home Office register or the company's own website.
Yes, Adaptimmune Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Adaptimmune Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Adaptimmune Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Adaptimmune Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.